Johnson & Johnson JNJ
NYSE
| 09/27/2026 | 06/28/2026 | 03/29/2026 | 12/28/2025 | 09/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 99.34B | 97.93B | 96.36B | 94.19B | 92.15B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 99.34B | 97.93B | 96.36B | 94.19B | 92.15B |
| Cost of Revenue | 32.02B | 31.21B | 30.80B | 30.07B | 29.16B |
| Gross Profit | 67.32B | 66.72B | 65.56B | 64.13B | 62.99B |
| SG&A Expenses | 24.83B | 24.50B | 24.00B | 23.13B | 22.74B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.93B | 70.81B | 69.77B | 67.86B | 67.62B |
| Operating Income | 26.41B | 27.12B | 26.59B | 26.33B | 24.53B |
| Income Before Tax | 17.74B | 25.20B | 24.94B | 32.58B | 31.50B |
| Income Tax Expenses | 1.64B | 4.16B | 3.90B | 5.78B | 6.38B |
| Earnings from Continuing Operations | 16.10K | 21.04K | 21.04K | 26.80K | 25.12K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.10B | 21.04B | 21.04B | 26.80B | 25.12B |
| EBIT | 26.41B | 27.12B | 26.59B | 26.33B | 24.53B |
| EBITDA | 34.50B | 34.87B | 34.33B | 33.84B | 31.92B |
| EPS Basic | 6.66 | 8.71 | 8.71 | 11.11 | 10.42 |
| Normalized Basic EPS | 6.79 | 7.04 | 6.93 | 7.01 | 6.58 |
| EPS Diluted | 6.59 | 8.63 | 8.65 | 11.05 | 10.36 |
| Normalized Diluted EPS | 6.71 | 6.98 | 6.88 | 6.97 | 6.54 |
| Average Basic Shares Outstanding | 9.66B | 9.66B | 9.66B | 9.66B | 9.65B |
| Average Diluted Shares Outstanding | 9.77B | 9.75B | 9.73B | 9.71B | 9.70B |
| Dividend Per Share | 5.28 | 5.24 | 5.20 | 5.14 | 5.08 |
| Payout Ratio | 79.01% | 59.99% | 59.52% | 46.19% | 48.70% |